Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
33.73
+0.21 (0.63%)
Mar 28, 2024, 2:55 PM EDT - Market open

HRMY Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
582.02437.86305.44159.7460
Revenue Growth (YoY)
32.93%43.35%91.21%2564.59%--
Cost of Revenue
121.2483.4855.5227.741.580
Gross Profit
460.79354.37249.921324.420
Selling, General & Admin
192.69163.3132.0395.5780.7329.07
Research & Development
76.0670.8930.3719.4569.612.37
Operating Expenses
268.76234.19162.39115.02150.3241.44
Operating Income
192.03120.1987.5316.99-145.9-41.44
Interest Expense / Income
23.7618.824.1928.226.07-1.54
Other Expense / Income
-5.12-3.325.9125.71--
Pretax Income
173.4104.6937.43-36.94-151.98-39.9
Income Tax
44.54-76.782.83000
Net Income
128.85181.4734.6-36.94-151.98-39.9
Preferred Dividends
00026.935.2330.19
Net Income Common
128.85181.4734.6-63.85-187.21-70.08
Net Income Growth
-28.99%424.52%----
Shares Outstanding (Basic)
5959582689
Shares Outstanding (Diluted)
6061592689
Shares Change
-1.19%3.20%129.72%231.37%-12.19%-
EPS (Basic)
2.173.070.60-2.48-24.07-7.91
EPS (Diluted)
2.132.970.58-2.48-24.07-7.91
EPS Growth
-28.28%412.07%----
Free Cash Flow
219.08144.2998.26-2.99-75.59-40.14
Free Cash Flow Per Share
3.682.441.71-0.12-9.72-4.53
Gross Margin
79.17%80.93%81.82%82.64%73.69%-
Operating Margin
32.99%27.45%28.66%10.63%-2433.76%-
Profit Margin
22.14%41.44%11.33%-39.97%-3122.74%-
Free Cash Flow Margin
37.64%32.95%32.17%-1.87%-1260.80%-
Effective Tax Rate
25.69%-73.35%7.56%---
EBITDA
221.51146.8780.461.51-142.69-41.26
EBITDA Margin
38.06%33.54%26.34%0.95%-2380.22%-
Depreciation & Amortization
24.3623.3918.8410.243.210.18
EBIT
197.15123.4861.62-8.72-145.9-41.44
EBIT Margin
33.87%28.20%20.17%-5.46%-2433.76%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).